Literature DB >> 24338583

Outcome of 110 basal cell carcinomas of the eyelid treated with frozen section-controlled excision: mean follow-up over 5 years.

Antonio Giordano Resti1, Riccardo Sacconi, Nicola Baccelli, Francesco Bandello.   

Abstract

PURPOSE: To analyze the outcome and risk factors of recurrence in patients with basal cell carcinomas (BCCs) of the eyelid treated by en face frozen section-controlled (FSC) excision with a mean follow-up over 5 years.
METHODS: This was a retrospective series of 108 patients with 110 biopsy-proven eyelid BCCs. All lesions were excised with 2 mm margins clinically free from neoplasia at clinical examination. For each tumor, en face frozen section examination of surgical margins was employed for the histologic confirmation before the reconstruction. Subsequently, all margins were submitted for permanent paraffin sections.
RESULTS: Of 110 malignancies, 80.9% represented primary carcinomas and 19.1% secondary ones. The overall recurrence rate was 1.8%, with a mean follow-up of 72.4 months (range 30-167). The mean time between the excision of the lesion and the diagnosis of the recurrence was 24 months (range 20-28). No recurrences were observed in 62 tumors followed up for at least 5 years. Secondary BCCs were associated with a higher recurrence rate compared with primary BCCs (4.8% and 1.1%, respectively, p = 0.262).
CONCLUSIONS: The FSC excision of eyelid BCCs yields recurrence rates comparable to those of Mohs micrographic surgery at 5-year follow-up. Intraoperative microscopic margin control improves the cure rate of eyelid BCCs, and FSC excision with small margins (2 mm) clinically free from neoplasia is associated with easier reconstruction and better cosmetic and functional outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 24338583     DOI: 10.5301/ejo.5000405

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  7 in total

Review 1.  High-dose Rate Electronic Brachytherapy: A Nonsurgical Treatment Alternative for Nonmelanoma Skin Cancer.

Authors:  Ajay Bhatnagar; Rakesh Patel; William Philip Werschler; Roger I Ceilley; Robert Strimling
Journal:  J Clin Aesthet Dermatol       Date:  2016-11-01

Review 2.  Surgical Management of Periocular Cancers: High- and Low-Risk Features Drive Treatment.

Authors:  Richard C Allen
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

Review 3.  Clinical, Histopathological and Therapeutical Analysis of Inferior Eyelid Basal Cell Carcinomas.

Authors:  M Totir; C Alexandrescu; R Pirvulescu; S Gradinaru; M Costache
Journal:  J Med Life       Date:  2014

4.  The Importance of Frozen Section-Controlled Excision in Recurrent Basal Cell Carcinoma of the Eyelids.

Authors:  Berna Şahan; Ferda Çiftçi; Ferda Özkan; Vildan Öztürk
Journal:  Turk J Ophthalmol       Date:  2016-12-01

Review 5.  Management of keratinocyte carcinoma - Special considerations in the elderly.

Authors:  Alison Bailey; Brooke Vasicek; Joy Tao; Monica Janeczek; Andia Mitri; Rebecca Tung
Journal:  Int J Womens Dermatol       Date:  2019-05-18

6.  Intraoperative assessment of surgical margins using "en face" frozen sections in the management of cutaneous carcinomas.

Authors:  Ana Carolina Vasconcellos Guedes Otsuka; Eduardo Bertolli; Mariana Petaccia de Macedo; Clovis Antonio Lopes Pinto; João Pedreira Duprat Neto
Journal:  An Bras Dermatol       Date:  2022-07-05       Impact factor: 2.113

7.  The Use of Composite Flaps in the Management of Large Full-Thickness Defects of the Lower Eyelid.

Authors:  Shuo Fang; Chao Yang; Yuntong Zhang; Chunyu Xue; Hongda Bi; Haiying Dai; Xin Xing
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.